0000886163-15-000070.txt : 20150624
0000886163-15-000070.hdr.sgml : 20150624
20150624185226
ACCESSION NUMBER: 0000886163-15-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150622
FILED AS OF DATE: 20150624
DATE AS OF CHANGE: 20150624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOEHR MATTHEW W
CENTRAL INDEX KEY: 0001237556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 15950242
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES RD #200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-06-22
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001237556
FOEHR MATTHEW W
11119 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
1
0
0
President and COO
Common Stock
2015-06-22
4
M
0
23046.0
9.97
A
91174
D
Common Stock
2015-06-22
4
S
0
4546.0
95.77
D
86628
D
Common Stock
2015-06-22
4
S
0
15145.0
96.43
D
71483
D
Common Stock
2015-06-22
4
S
0
3355.0
97.47
D
68128
D
Common Stock
2015-06-22
4
M
0
2000.0
9.97
A
70128
D
Employee Stock Option (right to buy)
9.97
2015-06-22
2015-06-22
4
M
0
23046.0
0.0
D
2021-04-18
Common Stock
23046
109010
D
Employee Stock Option (right to buy)
9.97
2015-06-22
2015-06-22
4
M
0
2000.0
0.0
D
2021-04-18
Common Stock
2000
107010
D
The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 20, 2015, in accordance with Rule 10b5-1.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.99, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.00 to $96.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.00 to $97.89, inclusive.
Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/18/11.
By: Charles S. Berkman For: Matthew W. Foehr
2015-06-24